During the 14th Five-Year Plan (2021-25) period, the Taixing Economic Development Zone and Binjiang town adhered to an integrated development approach, yielding fruitful results.
The semaglutide active pharmaceutical ingredient manufactured by Space Peptides has successfully obtained a Drug Master File (DMF) from the U.S. Food and Drug Administration.
As industries continue to evolve, Taixing Economic Development Zone is accelerating the integration of technological innovation with industrial development to drive high-quality growth.
